We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Lantern Pharma Inc
6 own
6 watching
Current Price
$0
$0.13
(2.42%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
57.35M
52-Week High
6.5893
52-Week Low
4.05
Average Volume
0.02M
Dividend Yield
--
P/E Ratio
--
Market Capitalization57.35M52-Week High6.589352-Week Low4.05Average Volume0.02MDividend Yield--P/E Ratio--What does the Lantern Pharma Inc do?
We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies. Our portfolio of therapies consists of small molecules that others have tried, but failed, to develop into an approved commercialized drug, as well as new compounds that we are developing with the assistance of our A.I. platform and our biomarker driven approach. Our A.I. platform, known as RADR®, currently includes more than 275 million data points, and uses big data analytics (combining molecular data, drug efficacy data, data from historical studies, data from scientific literature, phenotypic data from trials and publications, and mechanistic pathway data) and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds. We were initially incorporated in the State of Texas in November 2013. In January 2020 we reincorporated in the State of Delaware. Our principal executive office is located at 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201 and our telephone number is (972) 277-1136. Our website is www.lanternpharma.com.
Read More
How much money does Lantern Pharma Inc make?
News & Events about Lantern Pharma Inc.
PR Newswire
1month ago
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial PR Newswire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO...
CNW Group - News Releases
1month ago
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Canada NewsWire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /CNW/ -- Reprocell USA, a CRO...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has formed a...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('AI') and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('AI') and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced expansions and...
Frequently Asked Questions
Frequently Asked Questions
What is Lantern Pharma Inc share price today?
Can Indians buy Lantern Pharma Inc shares?
How can I buy Lantern Pharma Inc shares from India?
Can Fractional shares of Lantern Pharma Inc be purchased?
What are the documents required to start investing in Lantern Pharma Inc stocks?
What is today’s traded volume of Lantern Pharma Inc?
What is today’s market capitalisation of Lantern Pharma Inc?
What is the 52-Week High and Low Range of Lantern Pharma Inc?
What percentage is Lantern Pharma Inc down from its 52-Week High?
What percentage is Lantern Pharma Inc up from its 52-Week Low?
Current Price
$0
$0.13
(2.42%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.